Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study - Pozo-Rosich, Patricia; Detke, Holland C.; Wang, Shufang; Doležil, David; Li, Lily Q.; Aurora, Sheena K.; Reuter, Uwe (Current medical research and opinion, 2022)
Keywords: Adolescent; Adult; Aged; Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized - adverse effects; CGRP; chronic migraine; Double-Blind Method; Galcanezumab; Humans; long-term; Middle Aged; Migraine Disorders - drug therapy; Migraine Disorders - prevention & control; open-label extension; preventive treatment; Treatment Outcome; Young Adult; Galcanezumab; chronic migraine; open-label extension; preventive treatment; CGRP; long-term